Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacogenetics in HIV therapy.

Sonia Rodríguez-Nóvoa1, Pablo Barreiro, Inmaculada Jiménez-Nacher

  • 1Pharmacokinetic Unit, Hospital Carlos III, Madrid, Spain.

AIDS Reviews
|August 12, 2005
PubMed
Summary

Genetic variations significantly impact how individuals process antiretroviral drugs, affecting efficacy and toxicity. Pharmacogenetics aims to personalize treatment by understanding these genetic differences in drug metabolism.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HIV-2 infection in Europe - persistence by migrant flows from West Africa but low spillover into the native population.

Le infezioni in medicina·2026
Same author

A novel ABCA1 variant associated with impaired platelet production contributing to thrombocytopenia in a family with Tangier disease.

Journal of clinical lipidology·2026
Same author

Disseminated paracoccidioidomycosis in a migrant from Paraguay.

Journal of travel medicine·2025
Same author

The cascade of care for hepatitis B - any lessons from the HIV field?

Expert review of anti-infective therapy·2025
Same author

Clinical, Biochemical and Molecular Characterisation of Newborns With Fatty Acid β-Oxidation Disorders: Novel Variants in the ACADM , ACADVL and SLC22A5 Genes.

Clinical genetics·2025
Same author

Functional Analysis of 3'UTR Variants at the <i>LDLR</i> and <i>PCSK9</i> Genes in Patients with Familial Hypercholesterolemia.

Human mutation·2025

Area of Science:

  • Pharmacogenetics
  • Molecular Biology
  • Clinical Pharmacology

Background:

  • Standard antiretroviral drug doses show significant interindividual variability in plasma concentrations and toxicity.
  • This variability stems from multifactorial causes including metabolism, drug interactions, compliance, disease, and genetic factors.
  • Pharmacogenetics investigates the genetic basis of drug disposition variability to enable individualized therapy.

Purpose of the Study:

  • To review known genetic polymorphisms associated with altered antiretroviral pharmacokinetics.
  • To highlight the influence of these polymorphisms on antiretroviral drug efficacy and toxicity.
  • To underscore the importance of pharmacogenetics in optimizing antiretroviral therapy.

Main Methods:

  • Review of existing literature on pharmacogenetic studies of antiretrovirals.
  • Focus on genetic polymorphisms in drug-metabolizing enzymes and transporter proteins.
  • Analysis of how genetic variations affect drug pharmacokinetics and pharmacodynamics.

Main Results:

  • Genetic polymorphisms in metabolizing enzymes, like N-acetyltransferase-2 (NAT2), create distinct metabolizer phenotypes (slow, intermediate, fast).
  • Studies have identified specific genetic variations linked to altered antiretroviral pharmacokinetics.
  • These variations can significantly influence treatment outcomes, including drug efficacy and adverse events.

Conclusions:

  • Genetic polymorphisms are crucial determinants of interindividual variability in antiretroviral drug response.
  • Understanding these genetic factors is essential for developing personalized antiretroviral treatment strategies.
  • Pharmacogenetic insights can guide dose adjustments and drug selection to improve patient outcomes and reduce toxicity.

Related Experiment Videos